A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study.
EuroIntervention. 2024 Aug 19;20(16):1018-1028. doi: 10.4244/EIJ-D-24-00116.
PMID:39155755
Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L, Wong YH, Reddy VY, Boersma LVA, Bergmann MW, Doshi S, Kar S, Sievert H, Wehrenberg S, Stein K, Holmes DR Jr.
JACC Cardiovasc Interv. 2019 Jun 10;12(11):1055-1063. doi: 10.1016/j.jcin.2019.04.004.
PMID:31171282
The healing response of LAMax LAAC left atrial appendage occluder in a canine model: the potential influence of the implantation technique on the healing response.
Wu X, Ma D, Wan T, Meng Y, Chen Y, Shen Y, Huang W.
BMC Cardiovasc Disord. 2022 Jun 27;22(1):291. doi: 10.1186/s12872-022-02731-5.
PMID:35761168
Clinical effectiveness and safety comparison between direct oral anticoagulants and warfarin for nonvalvular atrial fibrillation patients following percutaneous left atrial appendage closure operation intervention: a prospective observational study.
Yao Y, Jin Q, Zhang X, Lv Q.
BMC Pharmacol Toxicol. 2025 Jan 2;26(1):1. doi: 10.1186/s40360-024-00834-7.
PMID:39748410
First Experience With Amulet in the United States: Early Insights From EMERGE LAA Postapproval Study.
Alkhouli M, Freeman JV, Ellis CR, Shah AP, Gada H, Coylewright M, Lo M, Makkar A, Agarwal H, Lakkireddy D.
JACC Cardiovasc Interv. 2024 Jan 19:S1936-8798(23)01553-4. doi: 10.1016/j.jcin.2023.11.027. Online ahead of print.